Helius Medical Technologies - Home

SIGNUP FOR NEWSLETTER

TSX: HSM     NASDAQ: HSDT

Call us: +1 877-564-0008

newsBanner

Menu

Stock Quote - HSM-T

*Delayed quote courtesy of Google.

Stock Quote - HSDT

*Delayed quote courtesy of Google.

2017 News Releases

Filters
List of articles in category 2017 News Releases
Title Date
Helius Medical Technologies Announces Publication of Multiple Sclerosis Pilot Study Results in Multiple Sclerosis Journal: Experimental, Translational and Clinical 09 Feb, 2017
Helius Medical Technologies Celebrates Grand Opening Ribbon Cutting Ceremony of New Corporate Facility in Newtown, PA 14 Aug, 2017
Helius Medical Technologies Provides Clarification on Clinical Trial Results and Confirms Intention to Include Traumatic Brain Injury (TBI) Registrational and Long-Term Treatment Trial Data to Support Application for Clearance by the FDA 17 Nov, 2017
Helius Medical Technologies Announces Closing of Final Tranche of Private Placement 29 Dec, 2017
Helius Medical Technologies Announces Closing of Second Tranche of Private Placement 28 Dec, 2017
Helius Medical Technologies Announces Closing of First Tranche of Private Placement 22 Dec, 2017
Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI) 08 Nov, 2017
Helius Medical Technologies to Report Results from Traumatic Brain Injury Clinical Trials 08 Nov, 2017
Helius Medical Technologies to Present at the Canaccord Genuity Medical Technologies and Diagnostics Conference on November 9, 2017 01 Nov, 2017
Helius Medical Technologies Highlights Publication of Stroke Study From The Royal Melbourne Hospital in Australia Using Investigational PoNS™ Device 02 Oct, 2017
Helius Medical Technologies Appoints Dane C. Andreeff to Board of Directors 14 Sep, 2017
Helius Medical Technologies Announces Extension of Collaborative Research and Development Agreement (CRADA) with US Army 13 Sep, 2017
Helius Medical Technologies Announces Newly Constituted Scientific Advisory Board 31 Jul, 2017
Helius Medical Technologies and the United States Army Medical Research and Materiel Command Announce Last Subject Enrolled In TBI Registrational Clinical Trial 13 Jul, 2017
Helius Medical Announces Research Conducted at the Tactile Communication and Neurorehabilition Laboratory (TCNL) Using PoNS™Therapy 28 Jun, 2017
Helius Medical Announces Closing of CAD$7.0 Million Private Placement 28 Jun, 2017
Helius Medical Technologies Receives First of Two Human Performance Patents 23 May, 2017
Helius Medical Technologies Receives Two Medical Method Patents 17 Apr, 2017
Helius Medical Technologies Signs 5-Year Lease for Corporate Headquarters in Newtown, PA 10 Apr, 2017
Advocates Reveal State of Progress, Need for More Clinical Research During Brain Injury Awareness Month 01 Mar, 2017
Helius Medical Technologies Inc. Announces Upcoming Participation and Presentation at the Cowen and Company 37th Annual Healthcare Conference 22 Feb, 2017
Helius Medical Technologies Inc. Closes C$12.5 Million Public Offering of Class A Common Stock, Including Full Exercise of Over-Allotment Option 16 Feb, 2017
Helius Medical Technologies Inc. Announces CAD$10.8 Million Public Offering of Class A Common Stock 09 Feb, 2017
Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock 08 Feb, 2017
Helius Medical Technologies Announces Resignation of Director 03 Feb, 2017
Helius Medical Technologies Announces Filing of Final MJDS Base Shelf Prospectus 26 Jan, 2017
Helius Medical Technologies Announces Launch of Sixth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial 16 Jan, 2017
Helius Medical Technologies Announces Launch of Fifth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial 10 Jan, 2017
Helius Medical Technologies announces that its shelf registration filed on Form S-3 with the US Securities and Exchange Commission (SEC) has been made effective 09 Jan, 2017